Adriana Martini1, Adriano Ammirati1, Carlos Garcia2, Carolina Andrade1, Odete Portela3, Maysa S Cendoroglo4, Ricardo Sesso5. 1. Disciplina de Nefrologia, Departamento de Medicina, Universidade Federal de São Paulo, Rua Botucatu 740, São Paulo, SP, CEP 04023-900, Brazil. 2. Disciplina de Economia e Gestão em Saúde, Universidade Federal de São Paulo, São Paulo, Brazil. 3. Faculdade de Enfermagem, Universidade Federal de São Paulo, São Paulo, Brazil. 4. Disciplina de Geriatria, Universidade Federal de São Paulo, São Paulo, Brazil. 5. Disciplina de Nefrologia, Departamento de Medicina, Universidade Federal de São Paulo, Rua Botucatu 740, São Paulo, SP, CEP 04023-900, Brazil. rsesso@unifesp.br.
Abstract
PURPOSE: The diagnosis of chronic kidney disease (CKD) in elderly individuals has been increasing. The objective of this study was to evaluate physical, mental and social aspects in longevous elderly patients with CKD. METHODS: Eighty patients with CKD (stage 4 and 5, not on dialysis) and 60 longevous elderly (≥ 80 years) paired by gender and age living in the community were evaluated. Physical, cognitive, social and quality of life aspects were analyzed according to the following scales: Charlson comorbidity index, Medical Outcomes Study Short Form 36-Item (SF-36), Medical Outcomes Study, Boston Naming Test, verbal fluency test (animal naming), sit-to-stand test, gait speed, and the Mini-Mental state examination. RESULTS: Compared to the control group, the CKD group had a higher mean in the comorbidities index (3.5 ± 1.2 vs. 1.0 ± 1, respectively, p < 0.001). In the multivariate analysis, the CKD group presented worse performance in the SF-36 dimensions: 'physical functioning,' 'general health,' 'emotional functioning,' 'vitality,' and physical component summary. On the other hand, they presented better results for the 'mental health' dimension, in addition to lower social support, worse verbal fluency and worse results on the sit-to-stand test. CONCLUSIONS: Longevous patients with stage 4 or 5 CKD presented worse evaluation in several domains of physical and emotional functioning, lower social support and evidence of worse cognitive performance. These aspects should be taken into account in order to improve the care provided to these patients, improve their quality of life and prevent their morbidity.
PURPOSE: The diagnosis of chronic kidney disease (CKD) in elderly individuals has been increasing. The objective of this study was to evaluate physical, mental and social aspects in longevous elderly patients with CKD. METHODS: Eighty patients with CKD (stage 4 and 5, not on dialysis) and 60 longevous elderly (≥ 80 years) paired by gender and age living in the community were evaluated. Physical, cognitive, social and quality of life aspects were analyzed according to the following scales: Charlson comorbidity index, Medical Outcomes Study Short Form 36-Item (SF-36), Medical Outcomes Study, Boston Naming Test, verbal fluency test (animal naming), sit-to-stand test, gait speed, and the Mini-Mental state examination. RESULTS: Compared to the control group, the CKD group had a higher mean in the comorbidities index (3.5 ± 1.2 vs. 1.0 ± 1, respectively, p < 0.001). In the multivariate analysis, the CKD group presented worse performance in the SF-36 dimensions: 'physical functioning,' 'general health,' 'emotional functioning,' 'vitality,' and physical component summary. On the other hand, they presented better results for the 'mental health' dimension, in addition to lower social support, worse verbal fluency and worse results on the sit-to-stand test. CONCLUSIONS: Longevous patients with stage 4 or 5 CKD presented worse evaluation in several domains of physical and emotional functioning, lower social support and evidence of worse cognitive performance. These aspects should be taken into account in order to improve the care provided to these patients, improve their quality of life and prevent their morbidity.
Entities:
Keywords:
Chronic kidney disease; Dialysis; Mental assessment; Physical evaluation; Quality of life
Authors: Lesley A Stevens; Suying Li; Changchun Wang; Cindy Huang; Bryan N Becker; Andrew S Bomback; Wendy Weinstock Brown; Nilka Ríos Burrows; Claudine T Jurkovitz; Samy I McFarlane; Keith C Norris; Michael Shlipak; Adam T Whaley-Connell; Shu-Cheng Chen; George L Bakris; Peter A McCullough Journal: Am J Kidney Dis Date: 2010-03 Impact factor: 8.860
Authors: Sandhi M Barreto; Roberto M Ladeira; Bruce B Duncan; Maria Ines Schmidt; Antonio A Lopes; Isabela M Benseñor; Dora Chor; Rosane H Griep; Pedro G Vidigal; Antonio L Ribeiro; Paulo A Lotufo; José Geraldo Mill Journal: J Epidemiol Community Health Date: 2015-10-28 Impact factor: 3.710
Authors: Fausto Aloísio Pedrosa Pimenta; Maria Aparecida Camargos Bicalho; Marco Aurélio Romano-Silva; Edgar Nunes de Moraes; Nilton Alves de Rezende Journal: Rev Assoc Med Bras (1992) Date: 2013-07-12 Impact factor: 1.209
Authors: Ricardo Cintra Sesso; Antonio Alberto Lopes; Fernando Saldanha Thomé; Jocemir Ronaldo Lugon; Carmen Tzanno Martins Journal: J Bras Nefrol Date: 2016-03
Authors: Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh Journal: JAMA Date: 2012-12-12 Impact factor: 56.272
Authors: Simon R Walker; Ranveer Brar; Frederick Eng; Paul Komenda; Claudio Rigatto; Bhanu Prasad; Clara J Bohm; Leroy J Storsley; Navdeep Tangri Journal: Can J Kidney Health Dis Date: 2015-09-05